Inventor

ALBRIGHT JAY D

US69 patents

⚠️ This page may combine multiple inventors who share the name “ALBRIGHT JAY D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ALBRIGHT JAY D

AMERICAN CYANAMID CO

Tricyclic benzazepine vasopressin antagonists

Tricyclic benzazepine vasopressin antagonists

N-substituted-N[3-(1,2,4-triazolo[4,3-b]pyridazin-6-yl)phenyl]alkanamides, carbamates and ureas

[7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines

Aryl and heteroaryl[7-(aryl and heteroaryl)pyrazolo[1,5-a]pyrimidin-3-yl]methanones

Pyrazolo[1,5-a]pyrimidines and imidazo-[1,5-a]pyrimidines

N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto

Tricyclic benzazepine vasopressin antagonists

Tricyclic diazepine vasopressin antagonists and oxytocin antagonists

Renin inhibitors

(Pyridinyl)-1,2,4-triazolo[4,3-a]pyridines

Renin inhibitors

6-Phenyl-1,2,4-triazolo[4,3-b]pyridazines and their uses in treating anxiety

3-Substituted-7-[3-(imidazol-1-yl)phenyl]-pyrazolo[1,5-a]pyrimidines

Aryl and heteroaryl[[7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]methanones

Substituted pyrazolo (1,5-a)pyrimidines and their use as anxiolytic agents

Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors

Ortho-sulfonamido bicyclic hydroxamic acids as matrix metalloproteinase and TACE inhibitors

2,3,4,5-tetrahydro-1H-[1,4]-benzodiazepine-3-hydroxyamic acids

Tricyclic benzazepine vasopressin antagonists

Tricyclic thieno-azepine vasopressin antagonists

Novel 6-phenyl and substituted 6-phenyl-1,2,4-triazolo[4,3-b]pyridazines

2-Aryloxy-2-(phenoxyalkoxy)phenyl acetic acid and esters

Substituted 3-alkyl-6-phenyl-1,2,4-triazolo-[4,3-a]pyridines

Tricyclic benzazepine vasopressin antagonists

Tricyclic benzazepine vasopressin antagonists

(Substituted-phenyl)-1,2,4-triazolo[4,3-a]-pyrimidines and (substituted-phenyl)-1,2,4-triazolo[1,5-a]pyrimidines

Renin inhibitors

Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors

Tricyclic benzazepine vasopressin antagonists

Antilipidemicpara-[aryl(alkyl or alkenyl)amino]benzoic acid derivatives

6- And 8-heteroaryl-1,2,4-triazolo[4,3-b]pyridazines

Imidazo[1,5-a]pyrimidines

Imidazo[1,2-b]pyridazines

ω-Heteroaroyl(propionyl or butyryl)-L-prolines

Substituted 6-phenyl-5,6,7,8-tetrahydro-1,2,4-triazolo-[4,3-a]pyridines

Substituted thio-substituted benzyl-propionyl-L-prolines

Hypolipemic phenylacetic acid derivatives

Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors

Tricyclic benzazepine vasopressin antagonists

Process for the preparation of tricyclic-heterocycles

Angiotensin II receptor blocking 2,3,6 substituted quinazolinones

7-Heteroaryl[1,2,4]triazolo[1,5-a]pyrimidines

Fused heterocyclic azepines as vasopressin antagonists

Substituted N-(ω-aroylpropionyl) derivatives of α-amino acids and esters thereof

ω-Heteroaroyl(propionyl or butyryl)-L-prolines

ω-Heteroaroyl(propionyl or butyryl)-L-prolines

ω-Heteroaroyl(propionyl or butyryl)-L-prolines

AMERICAN HOME PROD

Tricyclic benzazepine vasopressin antagonists

WYETH CORP

Tricyclic vasopressin agonists